首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1407339

獸醫人工授精市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按動物類型、產品、最終用戶、地區和競爭細分

Veterinary Artificial Insemination Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Animal Type, by Product, by End User, by region, and Competition

出版日期: 2023年11月07日 | 出版商:

TechSci Research | 英文 176 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2022年，全球獸醫人工授精市場價值為20.4億美元，預計在預測期內將出現令人印象深刻的成長，到2028年複合CAGR為8.28%。獸醫人工授精是畜牧業領域使用的一種繁殖技術，以促進控制動物繁殖。它涉及通常透過非自然方法將雄性動物的精子有意且受控地引入雌性的生殖道。此技術具有多種優點，廣泛應用於牲畜、伴侶動物飼養和保育工作。人工授精使育種者能夠仔細控制和管理育種過程，以實現特定目標，例如改善遺傳性狀、提高生產力或保護稀有和瀕危物種。它降低了交配過程中疾病傳播的風險，因為動物不需要進行身體交配，從而最大限度地減少疾病在群體內的傳播。它可用於維持或增強族群內的遺傳多樣性，防止近親繁殖的負面影響。育種者可以選擇優秀的雄性和雌性進行育種，從而改善所需的性狀。

全球對肉、奶和蛋等動物源產品的需求不斷成長是一個重要的推動因素。人工授精用於改善牲畜的遺傳，提高其生產力，並滿足對這些產品不斷成長的需求。人工授精技術的不斷進步，包括使用性控精液、改進精液儲存和運輸以及生殖管理軟體，使這一過程更加高效，對畜牧生產者更具吸引力。人工授精可以降低交配過程中動物間疾病傳播的風險。這對於疾病可能對牲畜產生重大影響的地區尤其重要。使畜牧業變得更永續和環境友善的壓力越來越大。人工授精可用於最佳化生產、減少環境足跡並提高資源效率。

主要市場促進因素

市場概況
預測期	2024-2028
2022 年市場規模	20.4億美元
2028 年市場規模	32.5億美元
2023-2028 年CAGR	8.28%
成長最快的細分市場	亞太地區
最大的市場	北美洲

技術進步

牛精英有限責任公司
- Business Overview
- Company Snapshot
- Products & Services
- Financials (In case of listed companies)
- Recent Developments
- SWOT Analysis
農業科技公司
- Business Overview
- Company Snapshot
- Products & Services
- Financials (In case of listed companies)
- Recent Developments
- SWOT Analysis
IMV技術
- Business Overview
- Company Snapshot
- Products & Services
- Financials (In case of listed companies)
- Recent Developments
- SWOT Analysis
泰克活動
- Business Overview
- Company Snapshot
- Products & Services
- Financials (In case of listed companies)
- Recent Developments
- SWOT Analysis
碩騰公司
- Business Overview
- Company Snapshot
- Products & Services
- Financials (In case of listed companies)
- Recent Developments
- SWOT Analysis
紐勤公司
- Business Overview
- Company Snapshot
- Products & Services
- Financials (In case of listed companies)
- Recent Developments
- SWOT Analysis
國際豬遺傳學
- Business Overview
- Company Snapshot
- Products & Services
- Financials (In case of listed companies)
- Recent Developments
- SWOT Analysis
選擇賽雷斯公司
- Business Overview
- Company Snapshot
- Products & Services
- Financials (In case of listed companies)
- Recent Developments
- SWOT Analysis
GENEX合作社
- Business Overview
- Company Snapshot
- Products & Services
- Financials (In case of listed companies)
- Recent Developments
- SWOT Analysis
Genus PLC（ABS Global）
- Business Overview
- Company Snapshot
- Products & Services
- Financials (In case of listed companies)
- Recent Developments
- SWOT Analysis

第 17 章：策略建議

第 18 章：關於我們與免責聲明

簡介目錄

Product Code: 13019

Global Veterinary Artificial Insemination Market has valued at USD 2.04 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.28% through 2028. Veterinary artificial insemination is a reproductive technique used in the field of animal husbandry to facilitate controlled breeding of animals. It involves the deliberate and controlled introduction of sperm from a male animal into the reproductive tract of a female, typically through non-natural methods. This technique offers several advantages and is widely used in livestock, companion animal breeding, and conservation efforts. Artificial insemination allows breeders to carefully control and manage the breeding process to achieve specific goals, such as improving genetic traits, increasing productivity, or preserving rare and endangered species. It reduces the risk of disease transmission during mating, as animals don't need to physically mate, thereby minimizing the spread of diseases within a population. It can be used to maintain or enhance genetic diversity within a population, preventing the negative effects of inbreeding. Breeders can select superior males and females for breeding, leading to the improvement of desirable traits.

The increasing global demand for animal-derived products, such as meat, milk, and eggs, is a significant driver. Artificial insemination is used to improve the genetics of livestock, enhancing their productivity, and meeting the rising demand for these products. Ongoing advancements in artificial insemination techniques, including the use of sexed semen, improved semen storage and transport, and reproductive management software, are making the process more efficient and attractive to livestock producers. Artificial insemination can reduce the risk of disease transmission between animals during mating. This is particularly important in regions where diseases can have a significant impact on livestock. There is increasing pressure to make animal agriculture more sustainable and environmentally friendly. Artificial insemination can be used to optimize production, reduce the environmental footprint, and enhance resource efficiency.

Key Market Drivers

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 2.04 Billion
Market Size 2028	USD 3.25 Billion
CAGR 2023-2028	8.28%
Fastest Growing Segment	Asia Pacific
Largest Market	North America

Technological Advancements

The development of sexed semen technology allows for the selection of the desired gender of the offspring. This is particularly important in livestock breeding to meet specific production goals. Sexed semen has applications in various species, including cattle, swine, and horses. Improved techniques for the freezing and storage of semen and embryos have extended their viability and facilitated global trade in genetic material. Cryopreservation allows for the long-term preservation of genetic resources and the sharing of valuable genetic material between regions. Advanced software systems help breeders and veterinarians manage and monitor reproductive processes more effectively. These systems track the estrus cycle, manage breeding schedules, and provide data analytics to optimize breeding programs. IVF techniques have been adapted for use in veterinary artificial insemination. This technology allows for the fertilization of eggs outside the animal's body, which is particularly beneficial for preserving genetic material and enhancing breeding programs.

High-quality ultrasound machines and imaging technologies enable veterinarians to monitor the reproductive health of animals more effectively. These tools help in diagnosing pregnancy, identifying reproductive issues, and optimizing the timing of artificial insemination. Advances in genetic profiling and selection techniques, including DNA testing and genomics, have revolutionized the ability to identify desirable traits in animals. Breeders can make more informed decisions about which animals to inseminate and which to use as donors of genetic material. Embryo transfer techniques have become more sophisticated, allowing for the collection and transfer of embryos between animals. This technology is especially valuable in elite breeding programs, allowing for the multiplication of genetic material from a single superior donor. Improvements in semen collection, processing, and quality control techniques ensure that semen samples are of the highest quality, leading to better insemination outcomes. Microfluidic devices and lab-on-a-chip technologies are being used to enhance the sorting and analysis of sperm cells. These technologies improve the accuracy of sexed semen sorting and selection. AI and data analytics are employed in the analysis of breeding data to predict the most suitable time for insemination and to identify genetic markers associated with desirable traits. Semen extenders, which help maintain the viability and fertilization capacity of sperm during storage and transport, have improved, contributing to more successful artificial insemination. This factor will help in the development of the Global Veterinary Artificial Insemination Market.

Increasing need of Disease Prevention and Control

Artificial insemination minimizes the direct physical contact between animals during mating, reducing the risk of disease transmission. This is especially important in industries where diseases can have severe economic consequences, such as livestock farming. Disease outbreaks can be devastating for animal agriculture. The controlled and isolated nature of artificial insemination facilities enhances biosecurity measures, preventing the entry and spread of pathogens on the farm. In the event of a disease outbreak, the loss of breeding animals can be catastrophic. Artificial insemination helps preserve valuable genetics, even if the breeding animals succumb to disease. This is crucial for maintaining and improving the quality of the livestock population. Disease outbreaks can result in stress for animals, and stress can negatively impact reproduction. Artificial insemination is a low-stress method of reproduction that minimizes disturbances, ensuring better reproductive performance even in the face of disease-related stressors. Artificial insemination often involves rigorous health checks and monitoring of the animals involved in the process. This helps in early disease detection and prevention, further enhancing the health and productivity of the herd.

In conservation and endangered species programs, disease prevention and control are of paramount importance. Artificial insemination allows for controlled breeding, reducing the risk of disease transmission within endangered populations. In some cases, natural mating can result in the persistence of disease reservoirs within a population. Artificial insemination reduces the risk of such reservoirs by controlling mating and limiting the spread of disease. In many regions, disease control and animal health regulations are strict. Artificial insemination, when performed in controlled and sanitary conditions, ensures compliance with these regulations. The ability to demonstrate the health and disease-free status of animals is crucial for international trade in genetic material. Artificial insemination practices often align with the sanitary and phytosanitary standards required for international trade. Artificial insemination can be part of long-term breeding strategies that consider disease risk and prevention. Producers can implement breeding programs that are robust in the face of disease challenges. This factor will pace up the demand of the Global Veterinary Artificial Insemination Market.

Growing Demand for Animal Products

As the demand for animal-derived products like meat, milk, and eggs continues to rise globally, livestock producers are under pressure to increase their production levels. Artificial insemination is a key tool for efficiently breeding and expanding herds or flocks to meet this demand. Artificial insemination enables livestock producers to selectively breed animals with desirable genetic traits that lead to improved productivity. This selective breeding helps produce animals that yield more meat, milk, or eggs, making it a crucial method to meet the increasing demand for high-quality animal products. Artificial insemination provides a higher level of control over the breeding process. This results in more efficient reproductive cycles, leading to quicker turnover and increased production. With concerns about the environmental impact of livestock agriculture, artificial insemination can contribute to sustainability. It allows for more efficient resource use, which can help mitigate the environmental footprint associated with animal agriculture.

Artificial insemination can reduce the risk of disease transmission during mating, which can be a significant concern in densely populated livestock operations. This enhances the overall health and welfare of the herd or flock, contributing to a steady and healthy production of animal products. Artificial insemination provides greater control over genetic traits, leading to more consistent product quality. This is essential for meeting the standards and expectations of consumers who demand reliable and high-quality animal products. Artificial insemination can shorten the generation interval, leading to faster genetic improvement in livestock. This means that desired traits are propagated more quickly through the herd, improving the efficiency of breeding. In many regions, there are stringent regulations governing animal husbandry and food safety. Artificial insemination can help producers meet these regulatory standards by ensuring the quality of genetic material used in breeding. In addition to traditional livestock farming, there is a growing demand for specialized breeding programs, such as those focused on rare or endangered species and specific genetic traits. Artificial insemination supports these programs by providing precise breeding control. As consumers become more conscious of animal welfare, food safety, and sustainability, they are willing to pay a premium for products derived from animals bred using advanced and humane reproductive methods. Artificial insemination can meet these consumer preferences. This factor will accelerate the demand of the Global Veterinary Artificial Insemination Market.

Key Market Challenges

Genetic Diversity and Inbreeding

Genetic diversity is crucial for the long-term health and adaptability of animal populations. Inbreeding, or the mating of closely related individuals, can lead to a loss of genetic diversity. Artificial insemination can contribute to maintaining genetic diversity by introducing genetic material from diverse donors. Inbreeding depression occurs when closely related animals are bred, leading to the expression of harmful recessive traits and a decrease in overall fitness and performance. Artificial insemination allows breeders to carefully select mating pairs, reducing the risk of inbreeding and its negative consequences. Artificial insemination is often used in the conservation of rare and endangered species. In these cases, genetic diversity is of paramount importance. Artificial insemination can help ensure that valuable genetic material is preserved, and that inbreeding is minimized. Selective breeding practices sometimes prioritize specific traits, such as high milk production or disease resistance, which can inadvertently lead to reduced genetic diversity if not managed carefully. Artificial insemination allows for controlled breeding while preserving genetic variety. In some livestock industries, there is a risk of overemphasizing certain genetic traits, which can lead to reduced genetic diversity. Artificial insemination can help maintain diverse breeding lines while still achieving desired production traits. Advances in data analytics and genetics have enabled more precise breeding programs. Artificial insemination can help implement these data-driven breeding strategies that optimize genetic diversity while meeting production goals.

Economic Factors

The cost of artificial insemination services can be a barrier for some livestock producers. High service fees and associated costs, such as semen collection and storage, may limit the adoption of artificial insemination, particularly in regions with smaller-scale or resource-constrained operations. Producers, especially in developing countries, may find it challenging to afford the cost of artificial insemination services and associated technologies. This can limit the use of advanced reproductive methods, despite the potential benefits. During economic downturns or financial crises, livestock producers may cut costs, and this can include reducing expenses related to artificial insemination. Reduced investment in breeding services can affect the growth of the artificial insemination market. Price sensitivity among consumers can affect the demand for animal products. If animal product prices are low, producers may be less inclined to invest in artificial insemination services to increase production. The artificial insemination market often involves the exchange of genetic material across borders. Exchange rates and international trade policies can influence the cost of importing or exporting genetic material, affecting market dynamics. Economic factors can impact the availability of resources required for artificial insemination, such as skilled labor, infrastructure, and technology. Resource constraints can limit the expansion of the artificial insemination market.

Key Market Trends

Companion Animal Segment

The global trend of increasing pet ownership, particularly dogs and cats, has led to a growing demand for high-quality breeding services, including artificial insemination. More people are looking for specific breeds and desirable traits in their pets, which can be achieved through controlled breeding. The Companion Animal segment has seen the adoption of advanced reproductive technologies, such as in vitro fertilization (IVF) and semen sexing. These technologies allow pet owners and breeders to have more control over the breeding process and the traits of the offspring. There is a growing interest in preserving and maintaining rare and endangered dog and cat breeds. Artificial insemination can help breeders conserve these breeds by ensuring controlled and healthy reproduction. Pet owners are increasingly concerned about the health and genetic quality of their pets. Artificial insemination allows for careful screening and selection of breeding animals to produce healthier and genetically superior offspring. Companion animal breeders are under increasing scrutiny regarding animal welfare and ethical breeding practices. Artificial insemination can be considered a more humane and controlled method of reproduction, aligning with evolving ethical standards. The use of online platforms and mobile apps for connecting breeders, pet owners, and artificial insemination service providers has made it easier to access these services and find suitable breeding partners for pets.

Segmental Insights

Animal Type Insights

In 2022, the Global Veterinary Artificial Insemination Market largest share was held by Swine segment and is predicted to continue expanding over the coming years. Pork is a widely consumed meat around the world, and there is a consistent demand for high-quality pork products. Swine producers often use artificial insemination to improve the genetic traits of their breeding stock, increase productivity, and meet the global demand for pork. Artificial insemination allows swine producers to engage in selective breeding to achieve specific genetic traits, such as lean meat production, disease resistance, and high reproductive performance. This can lead to higher-quality and more productive swine herds. Artificial insemination provides better control over the breeding process, leading to improved reproductive efficiency. Swine producers can synchronize estrus cycles and inseminate sows with carefully selected boars, resulting in a higher success rate in reproduction. Artificial insemination can reduce the risk of disease transmission that can occur during natural mating. This is especially important in swine farming, as disease outbreaks can have significant economic impacts. Swine producers often seek to improve the genetic potential of their herds. Artificial insemination enables them to introduce genetic material from superior boars, which can lead to healthier and more productive swine populations.

Product Insights

In 2022, the Global Veterinary Artificial Insemination Market largest share was held by Sexed Semen segment and is predicted to continue expanding over the coming years. The use of sexed semen in artificial insemination allows livestock producers to have better control over the sex of the offspring. This is particularly valuable in animal agriculture, as it allows for the selective breeding of animals with specific traits, such as higher milk or meat production, disease resistance, or other desired characteristics. Sexed semen can lead to increased productivity in animal agriculture. For instance, in dairy farming, the ability to selectively breed female calves can result in a higher number of dairy-producing cows in the herd, leading to increased milk production. Sexed semen is used to enhance the genetic quality of the livestock population. By breeding only from the best-performing animals of a particular gender, producers can make significant genetic improvements over time. Advances in sexed semen technology have improved the accuracy of sex selection, making it more reliable for livestock producers. This increased reliability can boost the adoption of sexed semen. Sexed semen allows producers to avoid unnecessary culling of animals that do not fit the desired gender profile. This can be more cost-effective and ethical, leading to a preference for sexed semen.

End User Insights

In 2022, the Global Veterinary Artificial Insemination Market largest share was held by Animal Husbandry segment in the forecast period and is predicted to continue expanding over the coming years. Animal husbandry is a critical component of the global agriculture and food production industry. It encompasses the breeding and management of livestock, including cattle, swine, sheep, and other animals raised for meat, milk, wool, and other agricultural products. As such, it represents a substantial market for veterinary artificial insemination services. Livestock producers, particularly in the animal husbandry sector, have a strong incentive to improve the genetic traits of their animals. Artificial insemination allows them to selectively breed animals with desirable characteristics, such as higher milk or meat production, disease resistance, and other valuable traits. This selective breeding is crucial for maintaining and enhancing the quality of the livestock population. Artificial insemination offers producers greater control over their breeding programs. It allows them to optimize genetic outcomes and increase the efficiency of reproduction, resulting in better livestock performance and profitability. Animal husbandry is also concerned with maintaining the health and well-being of livestock. Artificial insemination can be used to minimize the transmission of diseases through natural mating, as it involves controlled, safe breeding practices. The animal husbandry segment covers a wide range of livestock species and breeds, from dairy and beef cattle to pigs, sheep, and poultry. This diversity leads to a substantial market for artificial insemination services and a variety of genetic resources.

Regional Insights

The North America region dominates the Global Veterinary Artificial Insemination Market in 2022. North America has been at the forefront of technological innovations in veterinary artificial insemination. The region has a strong history of investing in research and development, leading to the adoption of advanced reproductive technologies. The United States and Canada have substantial livestock industries, including cattle, swine, and poultry. The demand for artificial insemination services in these industries is significant, as it allows for the controlled breeding of animals with desirable genetic traits. North America has rigorous standards for animal husbandry and breeding practices. The use of artificial insemination is integral to maintaining and improving the genetic quality of livestock, which aligns with these high standards. The region benefits from access to quality genetic material, including semen and embryos, from both domestic and international sources. This facilitates the use of artificial insemination to improve genetic traits in livestock. North America has well-developed infrastructure to support the artificial insemination industry, including breeding centers, laboratories, and skilled professionals. This facilitates the widespread adoption of artificial insemination.

Key Market Players

Bovine Elite LLC

Agtech Inc.

IMV Technologies

Tek-Event

Zoetis Inc.

Neogen Corporation

Swine Genetics International

Select Sires Inc.

GENEX Cooperative

Genus PLC (ABS Global)

Report Scope:

In this report, the Global Veterinary Artificial Insemination Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Artificial Insemination Market, By Animal Type:

Cattle
Swine
Ovine & Caprine
Equine
Others

Veterinary Artificial Insemination Market, By Product:

Normal Semen
Sexed Semen

Veterinary Artificial Insemination Market, By End-User:

Animal Husbandry
Others

Veterinary Artificial Insemination Market, By region:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Veterinary Artificial Insemination Market.

Available Customizations:

Global Veterinary Artificial Insemination Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Artificial Insemination Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Animal Type (Cattle, Swine, Ovine & Caprine, Equine, Others)
- 5.2.2. By Product (Normal Semen, Sexed Semen)
- 5.2.3. By End User (Animal Husbandry, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2022)
5.3. Market Map

6. Asia Pacific Veterinary Artificial Insemination Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Animal Type
- 6.2.2. By Product
- 6.2.3. By End User
- 6.2.4. By Country
6.3. Asia Pacific: Country Analysis
- 6.3.1. China Veterinary Artificial Insemination Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Animal Type
    - 6.3.1.2.2. By Product
    - 6.3.1.2.3. By End User
- 6.3.2. India Veterinary Artificial Insemination Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Animal Type
    - 6.3.2.2.2. By Product
    - 6.3.2.2.3. By End User
- 6.3.3. Australia Veterinary Artificial Insemination Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Animal Type
    - 6.3.3.2.2. By Product
    - 6.3.3.2.3. By End User
- 6.3.4. Japan Veterinary Artificial Insemination Market Outlook
  - 6.3.4.1. Market Size & Forecast
    - 6.3.4.1.1. By Value
  - 6.3.4.2. Market Share & Forecast
    - 6.3.4.2.1. By Animal Type
    - 6.3.4.2.2. By Product
    - 6.3.4.2.3. By End User
- 6.3.5. South Korea Veterinary Artificial Insemination Market Outlook
  - 6.3.5.1. Market Size & Forecast
    - 6.3.5.1.1. By Value
  - 6.3.5.2. Market Share & Forecast
    - 6.3.5.2.1. By Animal Type
    - 6.3.5.2.2. By Product
    - 6.3.5.2.3. By End User

7. Europe Veterinary Artificial Insemination Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Animal Type
- 7.2.2. By Product
- 7.2.3. By End User
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Veterinary Artificial Insemination Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Animal Type
    - 7.3.1.2.2. By Product
    - 7.3.1.2.3. By End User
- 7.3.2. Germany Veterinary Artificial Insemination Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Animal Type
    - 7.3.2.2.2. By Product
    - 7.3.2.2.3. By End User
- 7.3.3. Spain Veterinary Artificial Insemination Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Animal Type
    - 7.3.3.2.2. By Product
    - 7.3.3.2.3. By End User
- 7.3.4. Italy Veterinary Artificial Insemination Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Animal Type
    - 7.3.4.2.2. By Product
    - 7.3.4.2.3. By End User
- 7.3.5. United Kingdom Veterinary Artificial Insemination Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Animal Type
    - 7.3.5.2.2. By Product
    - 7.3.5.2.3. By End User

8. North America Veterinary Artificial Insemination Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Animal Type
- 8.2.2. By Product
- 8.2.3. By End User
- 8.2.4. By Country
8.3. North America: Country Analysis
- 8.3.1. United States Veterinary Artificial Insemination Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Animal Type
    - 8.3.1.2.2. By Product
    - 8.3.1.2.3. By End User
- 8.3.2. Mexico Veterinary Artificial Insemination Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Animal Type
    - 8.3.2.2.2. By Product
    - 8.3.2.2.3. By End User
- 8.3.3. Canada Veterinary Artificial Insemination Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Animal Type
    - 8.3.3.2.2. By Product
    - 8.3.3.2.3. By End User

9. South America Veterinary Artificial Insemination Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Animal Type
- 9.2.2. By Product
- 9.2.3. By End User
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Veterinary Artificial Insemination Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Animal Type
    - 9.3.1.2.2. By Product
    - 9.3.1.2.3. By End User
- 9.3.2. Argentina Veterinary Artificial Insemination Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Animal Type
    - 9.3.2.2.2. By Product
    - 9.3.2.2.3. By End User
- 9.3.3. Colombia Veterinary Artificial Insemination Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Animal Type
    - 9.3.3.2.2. By Product
    - 9.3.3.2.3. By End User

10. Middle East and Africa Veterinary Artificial Insemination Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Animal Type
- 10.2.2. By Product
- 10.2.3. By End User
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Veterinary Artificial Insemination Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Animal Type
    - 10.3.1.2.2. By Product
    - 10.3.1.2.3. By End User
- 10.3.2. Saudi Arabia Veterinary Artificial Insemination Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Animal Type
    - 10.3.2.2.2. By Product
    - 10.3.2.2.3. By End User
- 10.3.3. UAE Veterinary Artificial Insemination Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Animal Type
    - 10.3.3.2.2. By Product
    - 10.3.3.2.3. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Veterinary Artificial Insemination Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

16.1. Bovine Elite LLC
- 16.1.1. Business Overview
- 16.1.2. Company Snapshot
- 16.1.3. Products & Services
- 16.1.4. Financials (In case of listed companies)
- 16.1.5. Recent Developments
- 16.1.6. SWOT Analysis
16.2. Agtech Inc.
- 16.2.1. Business Overview
- 16.2.2. Company Snapshot
- 16.2.3. Products & Services
- 16.2.4. Financials (In case of listed companies)
- 16.2.5. Recent Developments
- 16.2.6. SWOT Analysis
16.3. IMV Technologies
- 16.3.1. Business Overview
- 16.3.2. Company Snapshot
- 16.3.3. Products & Services
- 16.3.4. Financials (In case of listed companies)
- 16.3.5. Recent Developments
- 16.3.6. SWOT Analysis
16.4. Tek-Event
- 16.4.1. Business Overview
- 16.4.2. Company Snapshot
- 16.4.3. Products & Services
- 16.4.4. Financials (In case of listed companies)
- 16.4.5. Recent Developments
- 16.4.6. SWOT Analysis
16.5. Zoetis Inc.
- 16.5.1. Business Overview
- 16.5.2. Company Snapshot
- 16.5.3. Products & Services
- 16.5.4. Financials (In case of listed companies)
- 16.5.5. Recent Developments
- 16.5.6. SWOT Analysis
16.6. Neogen Corporation
- 16.6.1. Business Overview
- 16.6.2. Company Snapshot
- 16.6.3. Products & Services
- 16.6.4. Financials (In case of listed companies)
- 16.6.5. Recent Developments
- 16.6.6. SWOT Analysis
16.7. Swine Genetics International
- 16.7.1. Business Overview
- 16.7.2. Company Snapshot
- 16.7.3. Products & Services
- 16.7.4. Financials (In case of listed companies)
- 16.7.5. Recent Developments
- 16.7.6. SWOT Analysis
16.8. Select Sires Inc.
- 16.8.1. Business Overview
- 16.8.2. Company Snapshot
- 16.8.3. Products & Services
- 16.8.4. Financials (In case of listed companies)
- 16.8.5. Recent Developments
- 16.8.6. SWOT Analysis
16.9. GENEX Cooperative
- 16.9.1. Business Overview
- 16.9.2. Company Snapshot
- 16.9.3. Products & Services
- 16.9.4. Financials (In case of listed companies)
- 16.9.5. Recent Developments
- 16.9.6. SWOT Analysis
16.10. Genus PLC (ABS Global)
- 16.10.1. Business Overview
- 16.10.2. Company Snapshot
- 16.10.3. Products & Services
- 16.10.4. Financials (In case of listed companies)
- 16.10.5. Recent Developments
- 16.10.6. SWOT Analysis